Company: DNLI
Filing Date: 2025-05-06
Form Type: 10-Q
Source: 0001714899-25-000105
Chunk: 387

Company: Denali Therapeutics Inc.
Filing Date: 2025-05-06
Form: 10-Q
Item: Part II, Item 2
Chunk 387
---
 Incline XBRL document———Furnished herewith101.SCHInline XBRL Taxonomy Extension Schema Document.———Furnished herewith101.CALInline XBRL Taxonomy Extension Calculation Linkbase Document.———Furnished herewith101.DEFInline XBRL Taxonomy Extension Definition Linkbase Document.———Furnished herewith101.LABInline XBRL Taxonomy Extension Label Linkbase Document.———Furnished herewith101.PREInline XBRL Taxonomy Extension Presentation Linkbase Document.———Furnished herewith104The cover page from the Company's Quarterly Report on Form 10-Q for the three months ended March 31, 2025, formatted in Inline XBRL (contained in Exhibit 101)———Furnished herewith

*The certifications attached as Exhibits 32.1 and 32.2 that accompany this Quarterly Report on Form 10-Q are not deemed filed with the Securities and Exchange Commission and are not to be incorporated by reference into any filing of Denali Therapeutics Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Quarterly Report on Form 10-Q, irrespective of any general incorporation language contained in such filing. #Portions of this exhibit have been omitted pursuant to a request for confidential treatment and this exhibit has been filed separately with the SEC.

97

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. 

 DENALI THERAPEUTICS INC.Date:May 6, 2025By:/s/ Ryan J. WattsRyan J. Watts, Ph.D.President and Chief Executive Officer(Principal Executive Officer)Date:May 6, 2025By:/s/ Alexander O. SchuthAlexander O. Schuth, M.D.Chief Operating and Financial Officer(Principal Financial and Accounting Officer)

98